PCN30 COSTS RELATED TO ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN CANADA
May 1, 2008, 00:00
10.1016/S1098-3015(10)70208-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)70208-4/fulltext
Title :
PCN30 COSTS RELATED TO ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70208-4&doi=10.1016/S1098-3015(10)70208-4
First page :
Section Title :
Open access? :
No
Section Order :
854